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Abstract
Background: Exposure to the toxic metals arsenic and cadmium is associated with detrimental health effects
including cancers of various organs. While arsenic and cadmium are well known to cause adverse health effects at
high doses, the molecular impact resulting from exposure to environmentally relevant doses of these metals
remains largely unexplored.
Results: In this study, we examined the effects of in vitro exposure to either arsenic or cadmium in human TK6
lymphoblastoid cells using genomics and systems level pathway mapping approaches. A total of 167 genes with
differential expression were identified following exposure to either metal with surprisingly no overlap between the
two. Real-time PCR was used to confirm target gene expression changes. The gene sets were overlaid onto
protein-protein interaction maps to identify metal-induced transcriptional networks. Interestingly, both metal-
induced networks were significantly enriched for proteins involved in common biological processes such as
tumorigenesis, inflammation, and cell signaling. These findings were further supported by gene set enrichment
analysis.
Conclusions: This study is the first to compare the transcriptional responses induced by low dose exposure to
cadmium and arsenic in human lymphoblastoid cells. These results highlight that even at low levels of exposure
both metals can dramatically influence the expression of important cellular pathways.
Background
Arsenic and cadmium are ranked among the top ten
priority hazardous substances by the Agency for Toxic
Substances and Disease Registry (ATSDR) [1]. Exposure
to arsenic and cadmium can lead to adverse health out-
comes such as lung and kidney cancers as well as cardi-
ovascular disease and diabetes [2,3]. Further, exposure
to these two toxic and well-classified chemicals is of
particular interest because of their extensive global
impact [4-6]. For example, it is estimated that more
than 40 million people worldwide drink water contain-
ing arsenic at concentrations that exceed the World
Health Organization (WHO) and Environmental Protec-
tion Agency (EPA) drinking water guideline of 10 ppb
[7]. Also, humans are exposed to low levels of cadmium
through food consumption, typically ranging between 8
and 25 ug per day [3]. Smoking populations experience
higher levels of cadmium exposure, as one cigarette may
contain 1-2 ug cadmium [3].
Both arsenic and cadmium are classified as Group 1
carcinogens by the International Agency for Research
on Cancer (IARC) [4,5]. Arsenic exposure has been
linked to several types of cancer, including skin, lung,
liver, and bladder [5,8]. Proposed mechanisms of
arsenic-induced disease include oxidative stress, DNA
repair inhibition, and epigenetic events [8]. Likewise,
cadmium exposure has been associated with various
cancers, such as prostate, kidney, pancreas, and lung [3].
The probable mechanisms of cadmium carcinogenesis
are similar to those of arsenic and include aberrant gene
expression, inhibition of DNA damage repair and apop-
tosis, and oxidative stress [9]. Studies suggest that even
at low levels, chronic exposure to arsenic and cadmium
is associated with increased risk for disease including
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associate low level exposures of arsenic and cadmium
with many of these negative health outcomes remain
largely unknown.
In this study, we set out to contrast the cellular
responses of human TK6 lymphoblastoid cells upon
exposure to low, environmentally relevant doses of
arsenic and cadmium. The rationale for this research
was based on studies suggesting that differential gene
expression occurs in human cells following exposure to
low levels of either arsenic [12-15] or cadmium [16].
Here we characterized the effects of low dose exposure
to either arsenic or cadmium by examining changes in
the expression of genes and their associated biological
pathways and functions. We found that while the modi-
fied gene sets were distinct for each of the two metals,
similar biological pathways were modulated between the
two. Future research will extend these findings to iden-
tify modulated protein activity associated with such low
dose exposure.
Results
Metal-induced gene sets identified
In this study, human TK6 lymphoblastoid cells were
exposed to either arsenic (sodium arsenite) or cadmium
(cadmium chloride) at low, equimolar doses (0.1 μM)
for 24 hours (see Methods). These metal concentrations
were minimally cytotoxic with 99% cell survival for both
arsenic and cadmium (Table 1). RNA was extracted
from metal-exposed or mock-treated control cells and
hybridized to Affymetrix GeneChip
® Human Gene 1.0
ST arrays (see Methods). Differentially expressed genes
were identified using an ANOVA model (see Methods).
A total of 167 genes (209 probesets) were significantly
differentially expressed in the metal-exposed cells; 62 of
these genes were dysregulated in the arsenic-exposed
cells and 105 in the cadmium exposed cells (Table 1 see
Additional File 1: Arsenic-modulated genes, Additional
File 2: Cadmium-modulated genes). It should be noted
that the two metal-induced gene sets were distinct with
no overlap between them.
Metal-induced molecular networks enriched for numerous
biological processes
To identify molecular networks associated with low dose
arsenic or cadmium exposure, we analyzed the metal-
modulated gene sets for known interactions among their
encoded proteins (see Methods). For the arsenic gene
set, 41 of the 62 differentially expressed genes were eli-
gible for network generation (see Additional File 3:
Gene products in networks). For the cadmium gene set,
a total of 71 of the 105 differentially expressed genes
were eligible for network generation (see Additional File
3: Gene products in networks).
Through network analysis we identified that exposure
to either arsenic or cadmium exposure results in the
modulation of large interacting protein networks (e.g.
interactomes). The arsenic-induced interactome was
c o m p r i s e do fat o t a lo f1 0 3p r o t e i n s ,3 5o fw h i c hw e r e
encoded by transcripts that were differentially expressed
following exposure (p < 10
-22, Figure 1A, see Additional
File 3: Gene products in networks). Within this arsenic-
modulated interactome, 26 genes showed increased
expression and 9 genes showed decreased expression as
a result of arsenic exposure (Figure 1A, see Additional
File 3: Gene products in networks).
The cadmium-modulated interactome contained a total
of 167 proteins with significant interactions (p < 10
-18);
64 of these proteins were encoded by transcripts that
were differentially expressed following exposure (Figure
1B, see Additional File 3: Gene products in networks).
Within this large cadmium-modulated interactome, the
Table 1 Summary of biological responses of TK6 cells exposed to arsenic or cadmium
Arsenic (0.1 μM) Cadmium (0.1 μM)
Percent Survival 99% 99%
Genes Differentially Expressed (probesets) 62 (74) 105 (135)
Gene Set Enrichment
(FWER)
Cancer Module 88
(Liver, heart, lung) (0.33)
Cancer Module 88
(Liver, heart, lung) (0.49)
Cancer Module 55
(Liver, lung, breast) (0.33)
Cancer Module 55
(Liver, lung, breast) (0.49)
Cancer Module 23
(Liver, lung, prostate) (0.49)
Cancer Module 6
(Lung, prostate, liver) (0.34)
Transcription Factor Binding Site Enrichment (p-value) RBP-Jkappa (0.001) ZF5 (0.002)
Oct-1 (0.002) Sp1 (0.011)
E2F (0.015) SREBP-1 (0.016)
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Page 2 of 10expression of 29 genes was up-regulated and the expres-
sion of 35 genes was down-regulated (Figure 1B, see
Additional File 3: Gene products in networks).
Within the large cadmium and arsenic-induced inter-
actomes were smaller, more focused sub-networks. The
arsenic interactome was comprised of three sub-net-
works with p values ranging from 10
-27 to 10
-22 (Figure
1C, see Additional File 4: Metal modulated sub-net-
works). These arsenic-modulated sub-networks were
enriched for biological processes such as cellular
development (p < 10
-4), antimicrobial response (p < 10
-
3), carbohydrate metabolism (p < 10
-3), cardiovascular
disease (p < 10
-3), and cancer (p < 10
-3)( F i g u r e2 A ) .
Contained within the large interactome were genes with
known associations with cancer development and pro-
gression. These included interleukin 1 receptor antago-
nist (IL1RN), mitogen-activated protein kinase 8
interacting protein 3 (MAPK8IP3), ral guanine nucleo-
tide dissociation stimulator-like 4 (RGL4), cannabinoid
receptor 2 (CNR2) and lin-28 (LIN28).
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Figure 1 Molecular interactomes and sub-networks modulated in TK6 cells exposed to arsenic or cadmium.T w ol a r g ei n t e r a c t o m e s
were identified in TK6 cells exposed to (A) arsenic or (B) cadmium. The two most significant cancer-enriched sub-networks within the
interactomes were identified for (C) arsenic and (D) cadmium. Networks are displayed with symbols representing encoded proteins
corresponding to their RNA transcripts that were either directly up-regulated (red symbols), down-regulated (green symbols), or associated with
the modified transcripts (while symbols). P-values representing network significance are shown.
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Page 3 of 10As was seen in response to arsenic, we identified sig-
nificant sub-networks in the cadmium-modulated inter-
actome with p values ranging from 10
-31 to 10
-18 (Figure
1D, see Additional File 4: Metal modulated sub-net-
works). The five sub-networks are enriched for pro-
cesses involving cellular compromise (p < 10
-3),
carbohydrate metabolism (p < 10
-3), cardiovascular dis-
ease (p < 10
-3), cell cycle functions (p < 10
-3), and can-
cer (p < 10
-3) (Figure 2B). In the cadmium-modulated
interactome and within the significant sub-networks,
many proteins with known roles in tumorigenesis were
identified. Such proteins include breast carcinoma
amplified sequence 1 (BCAS1), endogenous retroviral
family W, env(C7), member 1 (ERVWE1), keratin 16
(KRT16), S100 calcium binding protein A2 (S100A2),
secreted frizzled-related protein 1 (SFRP1), and ST3
beta-galactoside alpha-2,3-sialyltransferase 1 (ST3GAL1),
and actin filament associated protein 1-like 2
(AFAP1L2). These analyses also show the enrichment of
transcripts that encode proteins involved in pathways
regulated through nuclear factor kappa-light-chain-
enhancer of activated B cells (NF-B) and p38 mitogen-
activated protein kinase (p38 MAPK) (see Additional
File 4: Metal modulated sub-networks, Figure E).
While the arsenic and cadmium-induced gene sets
shared no genes in common, we set out to establish
whether the metal-modulated genes map to common
pathways. For this, we combined the arsenic and cad-
mium gene lists and analyzed the resulting metal-modu-
lated molecular networks. Interestingly, the networks
showed overlap with both arsenic and cadmium-asso-
ciated gene products mapping to common pathways
including the p38 mitogen-activated protein kinase (p38
MAPK) and hepatocyte nuclear factor 4 (HNF-4) path-
ways (see Additional File 4: Metal modulated sub-
networks).
Cancer modules enriched in the metal-modulated gene sets
As an alternative approach to identify biological path-
ways that are modulated upon exposure to arsenic or
cadmium, we performed gene set enrichment analysis
(see Methods). We compared the metal-modulated gene
sets to genes known to be dysregulated under certain
physiological and environmental conditions (e.g. cancer
modules) [17]. These results showed significant enrich-
ment for two cancer modules common to both arsenic
and cadmium: cancer modules 88 and 55 which include
gene sets associated with liver, lung, heart, breast, and
prostate cancer (Table 1). In addition, the cadmium-
modulated gene set was uniquely enriched for cancer
modules 6 and 23 (Table 1).
Transcription factors identified that may mediate metal-
induced transcriptional responses
To identify regulatory mechanisms that potentially
underlie the metal-modulated transcript levels, we inves-
tigated whether binding sites for specific transcription
factors were computationally enriched in the promoter
regions of the metal-modulated gene sets (see Methods).
In the arsenic-induced gene set, computational analysis
of the promoter regions of the differentially expressed
genes identified a significant enrichment for the follow-
ing two transcription factors: EF2 transcription factor
(E2F) (p < 0.015), octamer-1 transcription factor (Oct-1)
(p < 0.002) and RBP-Jkappa transcription factor (p <
0.001) (Table 1). In the cadmium-modulated gene set,
the enriched transcription factors included sp1 tran-
scription factor (Sp1) (p < 0.011), sterol regulatory ele-
ment binding transcription factor 1 (SREBP-1) (p <
0.016), and zinc finger protein 161 homolog (ZF5) (p <
0.002) (Table 1). A comparison of the predicted gene
targets of these transcription factors shows the enrich-
ment for their putative activity in the cancer-associated
proteins in the cadmium sub-network. Specifically, ST3
beta-galactoside alpha-2,3-sialyltransferase 1 (ST3GAL1)
is predicted to be regulated by ZF5 and Sp1. Likewise,
keratin 16 (KRT16) is predicted to be regulated by Sp1
(see Additional File 5 Figure 1).
Microarray gene expression results validated using qRT-
PCR
Within each of the metal-modulated interactomes, tar-
get genes were selected and analyzed for their expres-
sion levels using quantitative real-time PCR (qRT-PCR).
Selected from the arsenic-modulated networks, qRT-
PCR analysis showed that StAR-related lipid transfer
(START) domain containing 9 (STARD9)w a sd o w n -
regulated by arsenic exposure (-1.31 fold change (FC)),
and methyltransferase like 1 (METTL1) was up-regu-
lated (+1.46 FC). Likewise, qRT-PCR analysis showed
that cannabinoid receptor 2 (CNR2) was down-regulated
(-1.26 FC). A comparison of the fold changes obtained
with qRT-PCR with those obtained by microarray shows
a high correlation (0.87) (see Additional File 6).
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Figure 2 Biological functions enriched in molecular networks
altered in TK6 cells exposed to arsenic or cadmium. The five
most significantly enriched biological functions within the (A)
arsenic or (B) cadmium-induced molecular networks are illustrated.
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Page 4 of 10Selected from the cadmium interactome, qRT-PCR
showed that actin filament associated protein 1-like 2
(AFAP1L2) was down-regulated (-0.76 FC,), and lin-28
homolog (LIN28) was up-regulated (+4.0 FC,) following
low dose cadmium exposure. qRT-PCR analysis showed
that S100 calcium binding protein A2 (S100A2)w a s
down-regulated (-1.27 FC). In order to confirm that
metallothionein genes were not differentially expressed
upon exposure to low-dose arsenic or cadmium, metal-
lothionein 1A (MT1A) was assessed and found to be
insignificant (p value ≥ 0.3). A comparison of the fold
changes obtained with qRT-PCR with those obtained by
microarray shows a high correlation (0.92) (see Addi-
tional File 6).
Discussion
In this study we set out to compare the transcriptional
responses and associated biological pathways modulated
in TK6 cells exposed to low levels of arsenic or cad-
mium. Our aim was to contrast the genomic responses
of TK6 cells exposed to either of these metals at envir-
onmentally relevant doses. Our rationale for the selec-
tion of TK6 lymphoblastoid cells is that they are well
characterized at the molecular level and have been used
to analyze cellular responses upon exposure to a host of
environmental agents, including arsenic [18-22]. Using
the most recently developed Affymetrix ST arrays that
more fully cover open reading frames across the gen-
ome, we established the differential gene expression
between untreated and metal-exposed TK6 cells. The
transcriptional effect of exposure was greater for the
cells exposed to cadmium than for arsenic with 105 and
62 genes, respectively. It was interesting to find that
there were no genes in common between the two gene
sets identified. The microarray gene expression results
were validated using real time PCR and a high correla-
tion (0.87-0.92) was found.
Using network analysis, we evaluated the effects of
exposure to the two metals by overlaying the differen-
tially expressed genes onto known molecular interaction
maps and identified two large interactomes of inter-con-
nected proteins. The most significantly enriched cellular
functions within these networks included processes
related to cancer, carbohydrate metabolism, and cardio-
vascular disease. Not surprisingly as their gene sets were
distinct, there were also biological functions that were
unique to TK6 cells exposed to either arsenic or cad-
mium. For example, TK6 cells exposed to arsenic modu-
lated biological pathways associated with cellular
development and antimicrobial response, whereas TK6
cells exposed to cadmium modulated cellular compro-
mise and cell cycle functions. It is important to note that
while the arsenic and cadmium-induced gene sets were
distinct with no overlap in genes, the metal-modulated
genes do map to common pathways. Specifically, the
arsenic and cadmium-associated gene products both map
to the p38 MAPK and HNF-4 pathways.
Arsenic exposure results in the modulation of transcripts
associated with cancer, cell proliferation, cell death, and
inflammation
Within the arsenic-modulated interactome, there were
gene products with known associations to cancer, cell
proliferation, cell death, and inflammation. These
include the protein products CNR2, IL1RN, LIN28,
MAPK8IP3, and RGL4. CNR2, found to be down-regu-
lated through both qRT-PCR and microarray analysis,
has several anticancer functions. For example, it inhibits
cell proliferation, reduces angiogenesis, reduces cell
migration and metastasis, and attenuates inflammatory
processes [23]. IL1RN, here down-regulated by arsenic
exposure, is known to inhibit the activity of IL-1, a
major human cytokine implicated in inflammatory
responses that contribute to tumor development [24].
Evidence also suggests that IL1RN activity may play an
important role in the development of cervical squamous
cell carcinoma [25]. Further, in a chronically arsenic
exposed population, Argos et al.f o u n dt h a tIL1RN was
down-regulated among individuals with skin lesions
compared to those without lesions [26]. Our microarray
results also highlight the up-regulation of LIN28 further
validated through qRT-PCR. LIN28 has known associa-
tions with cancer, as decreased transcription decreases
cancer metastasis [27].
Cadmium exposure results in the alteration of the
expression of genes involved in tumorigenesis, cell cycle,
apoptosis, and oxidative stress
The cadmium-modulated interactome contains gene
products with known involvement in tumorogenesis, cell
cycle, apoptosis, and oxidative stress. For example,
AFAP1L2 showed decreased expression levels as
assessed through both qRT-PCR and microarray analy-
sis. AFAP1L2 has been identified as one of six potential
gene markers of tumors exhibiting local aggressiveness
[28]. Also, S100A2 showed decreased transcript levels in
TK6 cells exposed to cadmium assessed through both
qRT-PCR and microarray analysis. S100A2 is a known
tumor suppressor that controls tumor progression and
growth [29,30]. S100A2 differential expression has been
observed in cancers such as laryngeal squamous cell car-
cinoma [31] and non-small cell lung cancer [32].
Another cancer-associated gene, SFRP1, is up-regulated
in TK6 cells exposed to cadmium. SFRP1 is an antago-
nist of Wnt signaling and is involved in apoptosis, cell
differentiation, and signal transduction [33,34]. A pre-
vious association between the Wnt signaling pathway
and cellular responses to cadmium exposure has been
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sure, is differentially expressed in several types of cancer
including bladder [36], ovarian [37], breast [38], and col-
orectal [39,40]. We note that these genes are involved in
cellular mechanisms that control cell growth and prolif-
eration and here they are altered in TK6 cells exposed
to low doses of cadmium.
Cadmium exposure has been associated with the acti-
vation of oxidative stress pathways [9]. Our findings
support that oxidative stress responsive genes and
potential regulatory pathways are altered in TK6 cells
exposed to low doses of cadmium. Here we find the
S100A2 gene is modulated by exposure to cadmium.
S100A2 is associated with oxidative stress in keratino-
cytes [41], and is down-regulated by ultraviolet B expo-
sure, possibly in response to free radical activity [42]. In
addition, our pathway analysis shows the enrichment for
NF-B and p38 MAP kinase-associated proteins altered
by cadmium exposure. Both of these molecules have
been shown to regulate genes associated with oxidative
stress [43].
Gene Set Enrichment Analysis shows that common cancer
gene sets are modulated by environmentally relevant
levels of arsenic and cadmium
We performed Gene Set Enrichment Analysis (GSEA)
to determine whether transcripts with common biolo-
gical functions were differentially expressed in the
metal-treated cells. Four cancer-related gene expres-
sion signatures (modules) altered by arsenic or cad-
mium were identified. Two of the signatures were
common for both the arsenic and cadmium-induced
gene sets. Specifically, cancer modules 88 and 55 were
enriched in both gene sets. Cancer module 55 resem-
bles a gene expression profile present in various
tumors including liver, lung, B lymphoma, and breast
cancer. Cancer module 88 resembles a gene expression
profile observed in various tumors including those of
the liver, lung and breast. The enrichment of cancer
module 6 in the cadmium-induced gene set represents
a cancer signature identified in liver, lung, prostate,
and breast cancers and also leukemia. The cadmium-
modulated genes were similar to those that control
liver functions, such as metabolism (module 23), that
are associated with liver, lung, prostate, and breast
cancer and leukemia and B lymphoma [44]. It is inter-
esting to note again that while no genes were com-
monly dysregulated between the two metal exposures,
here the gene set enrichment analysis identified com-
mon cancer-associated modules within both. Thus, this
analysis suggests that even low dose environmentally
relevant exposures to arsenic or cadmium can induce
similar gene expression signatures, reflective of those
seen in several types of cancer.
Promoter sites of metal-modulated genes are enriched
for transcription factors involved in cell cycle regulation
To identify transcription factors that may mediate the
transcriptional responses in TK6 cells exposed to arsenic
or cadmium, we employed computational prediction
analysis of transcription factor binding sites for both
metal-induced gene sets. Computational analysis was
used to identify transcription factors predicted as regula-
tors of the observed molecular response. Analysis of the
promoter regions of the arsenic-modulated genes
showed enrichment for E2F, Oct-1, and RBP-JKappa.
E2F regulates the expression of genes that generate pro-
teins required for cell cycle progression, cell prolifera-
tion, apoptosis, and cell differentiation [45,46]. Oct-1 is
induced by DNA damaging therapeutic agents through a
posttranscriptional mechanism that does not require the
tumor suppressor p53, suggesting that Oct-1 may play
an important role in p53-independent gene activation to
regulate cellular responses to DNA damage [47]. It has
been shown that RBP-JKappa is a repressor of NF-b2
transcription, which regulates the expression of genes
involved in cell cycle regulation and inflammation [48].
Transcription factor binding site enrichment analysis
of the promoter regions of the cadmium-modulated
genes showed significant enrichment for transcription
factors Sp1, SREBP-1, and ZP5. Sp1, an important med-
iator of the cell cycle [49], may activate IL-10 in
response to inflammatory signals [50] and play a role in
the cellular responses to DNA damage and tumor
metastasis [51,52]. Sp1 also has known involvement in
oxidative stress response pathways [43]. Interestingly,
Sp1 is a known regulator of two cancer-associated genes
in the cadmium-associated networks. Specifically, ST3
beta-galactoside alpha-2,3-sialyltransferase 1 (ST3GAL1)
and keratin 16 (KRT16) are regulated by Sp1. The Sterol
regulatory element-binding protein-1 (SREBP-1) regu-
lates the expression of lipogenic genes, such as Fatty
acid synthase (FAS) [53]. SREBP-1 activity has been seen
in both colorectal neoplasia and breast cancer [54].
Although no common transcription factors were identi-
fied between the arsenic and cadmium-modulated gene
sets, the induced transcriptional changes of the target
genes are associated with similar biological processes.
Comparison of metal-induced genomic response of TK6
cells to existing genomic studies
In an effort to gain further understanding of the rele-
vance of these findings, we compared the genes and
pathways identified here to existing genomic studies.
Specifically, we compared our findings to the gene
expression changes that were observed in a human
population in Thailand exposed to arsenic at varying
levels [55]. In that study, a total of 447 genes with
altered expression were associated with arsenic
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were also found to be differentially expressed here in
TK6 cells exposed to low-dose arsenic. As discussed
previously, IL1RN is a human cytokine involved in
inflammation and tumorigenesis [24]. Also, G3BP2 is
often over-expressed in human cancers, and has been
suggested to act as a negative regulator of the p53
tumor suppressor pathway [56]. In the previous study,
enrichment for NF-B binding sites in the arsenic-
modulated genes was identified. Interestingly, here we
find enrichment for NF-B-associated genes altered in
response to low-dose cadmium exposure, but not to
arsenic.
We further compared the results obtained here with
the metal-induced transcriptional response in yeast
exposed to various transition metals [57]. In the study
by Jin et al. the investigators exposed yeast to arsenic
and cadmium and compared the transcriptional
responses at various concentrations [57]. Two genes
modified here in response to arsenic exposure, namely
C1ORF123 and DNAJB5,w e r ea l s of o u n dt oh a v e
altered expression in yeast exposed to arsenic. There
were no genes with common transcriptional response
between the TK6 cells and yeast exposed to cadmium.
These genomic comparisons highlight some commonal-
ities in the transcriptional changes induced by arsenic
and cadmium exposure, but the larger lack of overlap
suggests that different transcriptional responses are
likely influenced by cell type, organism, and dose.
Conclusions
In this study, we identified genes with expression levels
that were significantly changed in TK6 cells exposed to
low doses of either arsenic or cadmium. Our selection
of these two metals was based on their environmental
prevalence and our interest in identifying biological pro-
cesses that may be modulated by low level exposure.
Using a systems level approach to examine genes and
their associated networks, we show that even low-level
exposure to these metals impacts gene expression. In
addition, both metals were found to modulate genes
that encode proteins with similar biological functions in
the cell. These results highlight that even at low doses,
exposure to either of these metals has an impact on the
expression of molecular networks associated with
important biological functions. These results suggest
that more research is needed to examine the biological
effects of low dose exposure to toxic metals as such
pathways are potentially modulated not only in vitro,
but modulated in vivo as well. Future research will
include the examination of protein activity associated
with the metal-modulated genes and predicted tran-
scription factors. In addition, these findings suggest that
s t u d i e se x a m i n i n gs a m p l e sf r o mh u m a n sw i t hk n o w n
low-level exposures to these metals would be warranted
and results compared to our in vitro studies.
Methods
Cell Type
The human TK6 lymphoblastoid cell line was obtained
from ATCC (Manassas, VA) and cultured according to
ATCC’s guidelines (RPMI 1640 with L-glutamine, Peni-
cillin-Streptomycin, FetalPlex™ Animal Serum
Complex).
Metal exposures
Sodium arsenite and cadmium chloride were purchased
from Sigma (St. Louis, MO). Human TK6 cells were pla-
ted at 1 × 10
6 cells/ml and treated with 0.1 μM of either
sodium arsenite or cadmium chloride for 24 hours.
These equimolar, nonlethal doses were equivalent to 7.5
ppb of arsenic and 11.2 ppb of cadmium. Cell survival
was assessed with the Trypan Blue Exclusion Assay
using a hemocytometer with a 1:1 cell dilution and a 1:5
Trypan Blue dilution. For the arsenic exposures, two
separate biological treatment replicates and two mock-
treated controls were performed for subsequent micro-
array analysis. Likewise, for the cadmium exposures, two
separate biological treatment replicates and two mock-
treated controls were performed for subsequent micro-
array analysis.
Microarray Processing
Total RNA was isolated from either arsenic or cadmium
treated and mock treated human TK6 cells using the
Qiagen’s RNeasy
® Kit (Qiagen, Valencia CA). RNA was
quantified with the NanoDrop™ 1000 Spectrophot-
ometer (Thermo Scientific, Waltham MA) and its integ-
rity was verified by the Agilent 2100 Bioanalyzer. RNA
was biotin-labelled according to the Affymetrix protocol
and hybridized to Affymetrix GeneChip
® Human Gene
1.0 ST arrays.
Differential Gene Expression Analysis
Data were first normalized using Robust Multi-Chip
Average (RMA) [58] and filtered for background noise
(> abs[30]), which resulted in a reduction of probesets
from 28869 to 20695 for arsenic and 21450 for cad-
mium. Differential gene expression was determined as
a significant difference in the expression of a gene
(exposed versus unexposed) where p < 0.01 (ANOVA
model, Partek). Network analyses were performed
using the Ingenuity software http://www.ingenuity.com.
Statistical analyses were carried out within Ingenuity
on both the arsenic and cadmium-modulated gene lists
to identify the most significantly altered biological
functions. Gene set enrichment analysis (GSEA) [17]
was performed using the GSEA desktop software [59].
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Page 7 of 10Significance is defined by the family wise error rate
(FWER) p-value, which describes the probability that
r e s u l t sa r ef a l s e l yp o s i t i v e .M i c r o a r r a yd a t ah a v eb e e n
submitted to the Gene Expression Omnibus (GEO)
repository (GSE20320).
Transcription Factor-binding Site Analysis
Transcription factor binding site analysis was performed
using the EXPANDER 2.0 Software http://acgt.cs.tau.ac.
il/expander/. For the analysis, Affymetrix probesets were
linked to sequence data for regions 1,000 base pairs
upstream and 200 base pairs downstream of the tran-
scription start sites, and these were analyzed for signifi-
cant enrichment of transcription factor binding sites.
Significance (p ≤ 0.016) was calculated where signifi-
cance is the probability of obtaining an equal or greater
number of sequences with a model match in a randomly
drawn sample of the same size as the input sequence
set.
Quantitative Real Time PCR Verification of Expression
Data
Expression levels of the selected genes within the inter-
actomes and sub-networks were validated with quantita-
tive real time PCR (qRT-PCR) using RNA obtained
from separate biological exposures (e.g. independent
experiments) as those used for the microarray analyses.
The forward and reverse primers were designed using
Integrated DNA Technologies’ Real Time PCR SciTool
http://www.IDTdna.com/SciTools. The Qiagen Quanti-
Tect SYBR Green PCR kit and Roche Lightcycler 480
were used for all qRT-PCR experiments. Fold changes
between treated and untreated samples were calculated
based on delta-delta cycle threshold (ddCt) values and
normalized with b-actin as a housekeeping gene. Signifi-
cance was calculated using a t-test.
Additional material
Additional file 1: Arsenic-modulated genes. Additional File 1 lists all
74 probesets (62 genes) that showed significantly altered transcript levels
resulting from arsenic exposure (0.1 μM for 24 hours). Corresponding
gene symbols, reference sequences IDs, and fold changes are included.
Additional file 2: Cadmium-modulated genes. Additional File 2 lists all
135 probesets (105 genes) that showed significantly altered transcript
levels resulting from cadmium exposure (0.1 μM for 24 hours).
Corresponding gene symbols, reference sequences, and fold changes are
included.
Additional file 3: Gene products in networks. Additional File 3 lists all
of the proteins contained within the arsenic and cadmium-induced
interactomes. Each protein is listed as either directly altered resulting
from arsenic or cadmium exposure or associated with the directly altered
transcripts. Also, proteins that are cancer-related are identified.
Additional file 4: Metal-modulated sub-networks.A d d i t i o n a lF i l e4
shows eight additional metal-modulated sub-networks. Arsenic sub-
networks include (A) TNF-alpha associated sub-network 2 and (B) HNF-4
associated sub-network 3. Cadmium sub-networks include (C) p53
associated sub-network 1, (D) MYC-associated sub-network 3, (E) NF-kB
associated sub-network 4, and (F) PI3K associated sub-network 5. Networks
are displayed with symbols representing encoded proteins corresponding
to their RNA transcripts that were either directly up-regulated (red symbols),
down-regulated (green symbols), or associated with the modified
transcripts (while symbols). Arsenic and cadmium gene sets were combined
and mapped to (G) p38 MAPK associated sub-network 1, and (H) HNF-4
associated sub-network 3. Networks are displayed with symbols
representing gene products of arsenic-modulated genes (red symbols) and
cadmium-modulated genes (green symbols).
Additional file 5: Genes with enriched transcription factor binding
sites. Metal-modulated genes and their predicted transcription factors
are listed.
Additional file 6: Comparison of gene expression levels of target
genes assessed with qRT-PCR and microarray. Fold changes in
transcript levels for (A) arsenic and (B) cadmium-exposed samples are
plotted for selected target genes. Correlations (R) between microarray
and qRT-PCR values are displayed.
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